Rocket One Inc.
RKTO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001711786
No open-market purchases or sales by Rocket One Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q3 2026, worth $1.09M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 14, 2026, 1:25 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Operating expenses | $12.4M | $8.22M | $7.69M | $11.1M | $14.1M |
| Research and development | $5.95M | $3.25M | $3.48M | $4.84M | $7.35M |
| Selling, general and administrative | $6.41M | $4.97M | $4.21M | – | – |
| Operating income | -$12.4M | -$8.22M | -$7.69M | -$11.1M | -$14.1M |
| Net income | -$12.5M | -$8.19M | -$7.85M | -$11.4M | -$14.3M |
| EPS, basic | $-0.90 | $-1.28 | $-2.30 | $-9.50 | – |
| EPS, diluted | $-0.90 | $-1.28 | $-2.30 | $-8.79 | – |
| Weighted shares, basic | 13.8M | 6.38M | 3.41M | 1.20M | – |
| Weighted shares, diluted | 13.8M | 6.38M | 3.41M | 1.20M | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Cash and equivalents | $6.25M | $7.04M | $9.29M | $6.43M | $8.54M |
| Total current assets | $6.86M | $7.64M | $9.43M | $6.73M | $10.6M |
| Total assets | $7.60M | $7.71M | $9.52M | $6.76M | $11.0M |
| Accounts payable | $823.7K | $412.1K | $35.6K | $695.0K | $361.0K |
| Total current liabilities | $1.45M | $831.2K | $678.7K | $1.39M | $867.8K |
| Total liabilities | $1.45M | $833.9K | $705.0K | $1.64M | $1.10M |
| Shareholders' equity | $6.15M | $6.88M | $8.82M | $5.12M | $9.88M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | – | – | – | – | – |
| Operating cash flow | -$9.80M | -$6.98M | -$8.45M | -$9.30M | -$12.1M |
| Stock-based compensation | $1.19M | $804.3K | $216.4K | $620.8K | $1.32M |
| Investing cash flow | -$300.0K | – | – | $1.16M | -$165.4K |
| Financing cash flow | $9.31M | $4.74M | $11.3M | $6.04M | $18.2M |
| Net change in cash | – | – | – | -$2.10M | $5.94M |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 12, 2026 | 24.9M | +60.5% | SEC |
| Aug 14, 2026 | 24.9M | +87.8% | SEC |
| May 14, 2026 | 19.1M | +44.8% | SEC |
| Mar 26, 2026 | 16.3M | +23.4% | SEC |
| Nov 11, 2025 | 15.5M | +124.7% | SEC |
| Aug 11, 2025 | 13.3M | +92.1% | SEC |
| May 9, 2025 | 13.2M | +170.2% | SEC |
| Mar 28, 2025 | 13.2M | +199.1% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.